A continuous arterial blood oxygen detection chip based on microfluidics technology and its preparation process
Through the continuous arterial blood oxygen detection chip using microfluidic control technology in blood oxygen detection, the dual-electrode system and salt bridge conductive dielectric is used to achieve high-precision, selectivity, continuous and real-time detection of arterial blood oxygen, solving the existing solutions Problems of detection delay and thrombosis in the technology.
Patent Information
- Application Number
- CN202310057148.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-01-17
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2043-01-17
AI Technical Summary
The existing blood oxygen detection methods cannot achieve continuous real-time detection, and minimally invasive detection has problems with time delays and measurement deviations in thrombosis and non-invasive detection.
Using a continuous arterial blood oxygen detection chip based on microfluidic control technology, including integrated electrochemical sensor elements and microfluidic channel elements, the Clark-type limit current sensor principle using a dual-electrode system, the salt bridge is used as the conductive dielectric, and the oxygen-permeable membrane is used as the gas filter. The device controls blood flow rate through the microfluidic pipeline design to achieve continuous detection of arterial blood oxygen.
It realizes high-precision, selectivity, continuous and real-time detection of arterial blood oxygen, reduces blood consumption, and improves the real-time and accuracy of detection.
Smart Images

Figure CN116106390B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of blood gas detection, in particular to a continuous arterial blood oxygen detection chip based on microfluidics technology and a preparation process thereof. Background Art
[0002] Oxygen is one of the essential substances for maintaining biological life activities. Physiological oxygen is one of the fundamental sources of human energy. Japanese Dr. Hideyo Noguchi once said, "Lack of oxygen is the source of all diseases."
[0003] Clinically, in order to determine oxygenation, determine the severity of respiratory failure and guide treatment, one of the necessary tests is to measure blood oxygen. Oxygen partial pressure (PO2) refers to the tension generated by oxygen molecules dissolved in plasma in a physical state (so it is also called oxygen tension). Under normal circumstances, the arterial oxygen partial pressure (PaO2) is about 100mmHg, and the venous oxygen partial pressure (PvO2) is about 40mmHg. PaO2 mainly depends on the oxygen partial pressure of the inhaled gas and the external respiratory function of the lungs, while PvO2 can reflect the internal respiratory status. Blood oxygen analysis refers to the use of a blood oxygen analyzer to measure the oxygen content dissolved in human blood and understand the respiratory function of the human body.
[0004] At present, clinical blood oxygen detection instrument analysis requires intermittent sampling and then sent to the analyzer or laboratory for testing. This detection method is an in vitro single-point detection. Blood is drawn once and a test card is used, which can only obtain blood physiological status information at a point in time. The test results are delayed and cannot accurately reflect the continuous and real-time changes in the patient's blood physiological state. Therefore, achieving continuous real-time detection of blood oxygen is a necessary research direction at present.
[0005] At present, the continuous blood oxygen detection proposed on the market can be divided into minimally invasive detection and non-invasive detection. Minimally invasive detection includes: intravascular implantation, intramuscular implantation, and subcutaneous implantation. Since there is a difference in the value of PO2 in human tissue and PO2 in arterial blood, new diagnostic standards are required for intramuscular implantation and subcutaneous implantation. Although intravascular implantation can realize continuous online blood oxygen detection and reflect the trend of blood oxygen changes, it is easy to form blood clots, which reduces or even interrupts the blood flow rate around the sensor and produces intermittent vasospasm. Non-invasive detection is transcutaneous blood oxygen analysis. This method has time delay and measurement deviation and cannot replace arterial blood oxygen. Summary of the invention
[0006] The technical problem to be solved by the present invention is to provide a continuous arterial blood oxygen detection chip based on microfluidics technology.
[0007] Another technical problem to be solved by the present invention is to provide a preparation process of the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology.
[0008] In order to solve the above technical problems, the technical solution of the present invention is:
[0009] A continuous arterial blood oxygen detection chip based on microfluidic technology includes an integrated electrochemical sensor element and an integrated microfluidic channel element. It adopts the Clark-type limiting current sensor principle of a dual-electrode system, uses a salt bridge as a conductive medium, and an oxygen-permeable membrane as a gas filter. At the same time, it adopts a microfluidic pipeline design. The flow resistance and blood flow rate are controlled by the microfluidic pipeline, so that blood can flow continuously through the surface of the oxygen sensor, thereby realizing continuous detection of arterial blood oxygen.
[0010] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology, the integrated electrochemical sensor element is composed of a glass substrate (1), an electrode layer (2), a salt bridge (3) and a filter layer (4) in sequence, wherein the glass substrate (1) serves as a substrate, and the electrode layer (2) is provided on its upper surface, and the salt bridge (3) in electrical contact with the electrode and the filter layer formed on the salt bridge (3) are provided on the electrode reaction region of the electrode layer (2); the Clark type limiting current sensor principle of a dual-electrode system is adopted, the salt bridge is used to fill the electrolyte tank and cover the dual electrodes, and the filter layer (4) is suitable for blocking other components in the gas medium except oxygen.
[0011] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology, the electrodes are double electrodes, namely a working electrode and a reference electrode, each electrode comprises a lead (2-1) and a reaction area (2-2), and the lead (2-1) and the reaction area (2-2) are in contact and connected.
[0012] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology, the electrode is prepared on a glass substrate by inkjet printing, evaporation, screen printing or magnetron sputtering technology, and then the reference electrode is chlorinated.
[0013] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology, the reference electrode is an Ag / AgCl reference electrode.
[0014] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology, the salt bridge is a hydrogel containing salt ions, such as a hydrogel containing zinc sulfate (ZnSO4).
[0015] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology, the salt bridge is prepared by the following method: 1.229g of sulfobetaine methacrylate (SBMA) is dissolved in 1mL of 0.1M anhydrous zinc sulfate, 6.78mg of monobromoacetic acid (MBAA) is added, ice-bathed for 30min, 2mg of ammonium sulfate (APS) and 2μL of tetramethylethylenediamine (TEMED) are added, and finally polymerized at 37°C to form a salt bridge.
[0016] Common electrolytes are solutions containing salt ions. Considering that the inevitable heating process in the chip processing will cause the volatilization of the electrolyte, the liquid electrolyte is large in volume and difficult to encapsulate or the chip volume is too large after encapsulation, a salt bridge is selected as the electrolyte. The salt bridge can fix the oxygen permeable membrane and the electrode while achieving conduction between the working electrode and the reference electrode, thereby improving the current baseline of the integrated electrochemical sensor; at the same time, the upper surface of the salt bridge and the oxygen permeable membrane is smooth after heating and polymerization, which has a good sealing effect, which is conducive to the miniaturization of the microfluidic chip, thereby reducing the consumption of blood.
[0017] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology, the filter layer (4) is an oxygen permeable membrane, the size of which is the same as that of the salt bridge, and completely covers and fits on the upper surface of the salt bridge.
[0018] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology, the integrated microfluidic channel element is composed of an electrolyte tank (5) and a packaging layer (6) in sequence, and the packaging layer (6) is arranged above the electrolyte tank (5); the electrolyte tank (5) is partially located above the electrode layer of the integrated electrochemical sensor element.
[0019] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology, the materials of the glass substrate and the integrated microfluidic channel element are polydimethylsiloxane (PDMS), and the glass substrate, electrolyte tank and packaging layer are bonded layer by layer by oxygen plasma (Plasma).
[0020] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology, the electrolyte tank (5) is a cavity of an annular structure with a hole in the middle, the hole is located directly above the reaction area of the electrode layer, and part of the cavity is located directly above the lead of the electrode layer. The hole is filled with a salt bridge, which is liquid before being heated and polymerized. After the liquid salt bridge fills the internal cavity of the electrolyte tank, the salt bridge and the oxygen permeable membrane are heated and polymerized, and a completely sealed cavity structure is formed on the upper surface of the electrolyte tank, which is in electrical contact with the electrode layer in the electrode reaction area.
[0021] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology, the lower surface of the packaging layer (6) is provided with a microfluidic flow path (7) which is in direct contact with the upper surface of the filter layer (4), and a liquid inlet and a liquid outlet are respectively provided at both ends of the microfluidic flow path.
[0022] Preferably, in the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology, the microfluidic flow path (7) adopts a curved regulating flow path.
[0023] The specific process of preparing the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology is as follows:
[0024] (1) The electrode layer is attached to the glass substrate by inkjet printing; the microfluidic flow path (curved regulating flow path) on the lower surface of the encapsulation layer is poured into the mold through the mold, and then heated (80°, 1h) to cure;
[0025] (2) bonding the electrolyte bath to the electrode layer and the glass substrate, wherein the glass substrate, the electrode layer and the electrolyte bath are treated with plasma (300 W, 30 s) respectively, and then heated (80° C., 30 min) after bonding;
[0026] (3) dripping the salt bridge into the middle hole of the electrolyte tank, and then covering it with a filter layer (oxygen permeable membrane) of the same size as the hole, and heating it at 37°C to solidify the salt bridge, so that the filter layer adheres to the upper surface of the salt bridge, and the middle of the electrolyte tank is sealed and flat;
[0027] (4) bonding the encapsulation layer to the electrolyte tank, treating with plasma (100 W, 30 s), and heating after bonding (80 ° C, 30 min);
[0028] (5) Preparation of the conductive part and the insulating part: The conductive wire is glued to the end of the lead of the electrode layer with conductive silver glue and heated at 60°C for curing; UV curing glue is dripped on the connection area between the conductive wire and the lead and irradiated with UV lamp for 5 minutes to achieve curing, thereby achieving the purpose of insulation.
[0029] Preferably, in the preparation process of the above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology, the processing materials selected for the electrolyte tank and the packaging layer are both polydimethylsiloxane (PDMS), and after surface modification by oxygen plasma (Plasma), the hydrophilicity of the polydimethylsiloxane (PDMS) surface is improved to improve its anti-adsorption performance and thus improve the anti-coagulation function of the chip.
[0030] Preferably, the preparation process of the above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology, the preparation process of the electrode layer is: use inkjet printing technology to print gold ink and silver ink on a glass substrate, and heat and sinter, add 100 μL of 50 mmol / L FeCl3 chloride electrode on the reference electrode for 20 seconds, and use a heating plate (C-MAG HP 10, IKATHERM, Germany) after printing, and heat and sinter at 250°C for 2 hours.
[0031] The inkjet printer used is the Jetlab4 inkjet printing system of MicroFab Company in the United States; the gold ink used is the UTDAuIJ ink of UT Dots, and the silver ink used is the Smart'Ink S-CS01130 ink of Sigma Company.
[0032] Beneficial effects:
[0033] The above-mentioned continuous arterial blood oxygen detection chip based on microfluidic technology proposes a new method for realizing the detection of trace blood samples using electrochemical sensors and microfluidic chips. The new structural design of this oxygen partial pressure detection chip makes the real-time and continuous detection of arterial blood oxygen and the miniaturization of blood oxygen analysis instruments possible for the first time. By using a salt bridge (solid hydrogel) instead of a common electrolyte, the problems of liquid volatilization caused by heating during processing and excessive chip volume caused by sealing during packaging are solved, which is conducive to reducing the sensing area and thus reducing blood consumption; the curve-type regulating flow path is used to control the flow resistance, and the real-time information of PO2 in arterial blood can be measured under the drive of arterial pressure to realize continuous detection of arterial blood oxygen. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 The overall structure of the continuous arterial blood oxygen detection chip based on microfluidic technology of the present invention includes a top view and a side view.
[0035] Figure 2 This is the working principle of the continuous arterial blood oxygen detection chip based on microfluidics technology described in the present invention.
[0036] Figure 3 It is a top view of the electrode layer structure of the continuous arterial blood oxygen detection chip based on microfluidic technology described in the present invention.
[0037] Figure 4 It is a top view of the electrolyte tank structure of the continuous arterial blood oxygen detection chip based on microfluidic technology described in the present invention.
[0038] Figure 5 It is a top view of the packaging layer structure of the continuous arterial blood oxygen detection chip based on microfluidic technology described in the present invention.
[0039] Figure 6 It is a curve showing the change of the current value of different quality control solutions of the continuous arterial blood oxygen detection chip based on microfluidics technology of the present invention.
[0040] Figure 7 It is the linear regression line of the current value and PO2 obtained by different quality control solutions of the continuous arterial blood oxygen detection chip based on microfluidic technology of the present invention.
[0041] In the figure: 1- glass substrate 2- electrode layer 2-1- lead 2-2- reaction area 3- salt bridge 4- filter layer 5- electrolyte tank 6- packaging layer 7- microfluidic flow path DETAILED DESCRIPTION
[0042] Example 1
[0043] like Figure 1-5 As shown, the continuous arterial blood oxygen detection chip based on microfluidic technology includes an integrated electrochemical sensor element and an integrated microfluidic channel element, adopts the Clark type limiting current sensor principle of a dual-electrode system, uses a salt bridge as a conductive medium, and an oxygen-permeable membrane as a gas filter. At the same time, a microfluidic pipeline design is adopted to control the flow resistance and blood flow rate through the microfluidic pipeline, so that blood can flow continuously through the oxygen sensor surface to achieve continuous detection of arterial blood oxygen. The specific structure is as follows:
[0044] The integrated electrochemical sensor element is composed of a glass substrate 1, an electrode layer 2, a salt bridge 3 and a filter layer 4 in sequence, wherein the glass substrate 1 is used as a substrate, the upper surface of which is the electrode layer 2, the electrode reaction area of the electrode layer 2 is the salt bridge 3 electrically contacting the electrode and the filter layer formed on the salt bridge 3; the electrode is a double electrode, namely a working electrode and a reference electrode, and the reference electrode is Ag / AgC l reference electrode, each electrode comprises a lead 2-1 and a reaction area 2-2, the lead 2-1 and the reaction area 2-2 are in contact and connected, the electrode is prepared on a glass substrate by inkjet printing technology, and then the reference electrode is chlorinated, the salt bridge is used to fill the electrolyte tank and cover the double electrodes, the salt bridge is a hydrogel containing salt ions, such as a hydrogel containing zinc sulfate (ZnSO4), and the salt bridge is prepared by the following method: 1.229g of sulfobetaine methacrylate (SBMA) is dissolved in 1mL of 0.1M anhydrous zinc sulfate, 6.78mg of monobromoacetic acid (MBAA) is added, ice water bath is performed for 30min, 2mg of ammonium sulfate (APS) and 2μL of tetramethylethylenediamine (TEMED) are added, and finally polymerized at 37°C to form a salt bridge; the filter layer (4) is an oxygen permeable membrane, suitable for blocking other components in the gas medium except oxygen.
[0045] The integrated microfluidic channel element is composed of an electrolyte tank 5 and an encapsulation layer 6 in sequence. The encapsulation layer 6 is arranged above the electrolyte tank 5; the electrolyte tank 5 is partially located above the electrode layer of the integrated electrochemical sensor element. The electrolyte tank 5 is a cavity of an annular structure, with a hole in the middle. The hole is located directly above the reaction area of the electrode layer, and part of the cavity is located directly above the lead of the electrode layer. The hole is filled with a salt bridge. The salt bridge is liquid before heating and polymerization. After the liquid salt bridge fills the internal cavity of the electrolyte tank, the salt bridge and the oxygen permeable membrane are heated and polymerized. The surface area of the oxygen permeable membrane is the same as the surface area of the salt bridge, and it completely covers and fits the upper surface of the salt bridge. The upper surface of the electrolyte tank forms a completely sealed cavity structure, which is in electrical contact with the electrode layer in the electrode reaction area. The lower surface of the encapsulation layer 6 is provided with a microfluid flow path 7, which adopts a curved adjustment flow path, is in direct contact with the upper surface of the filter layer 4, and is provided with a liquid inlet and a liquid outlet at both ends of the microfluid flow path.
[0046] The materials of the glass substrate and the integrated microfluidic channel element are both polydimethylsiloxane (PDMS), and the glass substrate, electrolyte tank, and encapsulation layer are bonded layer by layer through oxygen plasma (Plasma). The processing materials selected for the electrolyte tank and the encapsulation layer are both polydimethylsiloxane (PDMS), and after surface modification by oxygen plasma (Plasma), the hydrophilicity of the polydimethylsiloxane (PDMS) surface is improved to improve its anti-adsorption performance and thus improve the anti-coagulation function of the chip. Common electrolytes are solutions containing salt ions. Considering that the inevitable heating process in the chip processing will cause the volatilization of the electrolyte, the liquid electrolyte is large in volume and difficult to encapsulate or the chip volume is too large after encapsulation, a salt bridge is selected as the electrolyte. The salt bridge can fix the oxygen permeable membrane and the electrode while achieving conduction between the working electrode and the reference electrode, thereby improving the current baseline of the integrated electrochemical sensor; at the same time, the upper surface of the salt bridge and the oxygen permeable membrane is smooth after heating and polymerization, which has a good sealing effect, which is conducive to the miniaturization of the microfluidic chip, thereby reducing the consumption of blood.
[0047] The specific process of preparing the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology is as follows:
[0048] (1) The electrode layer is attached to the glass substrate by inkjet printing; the microfluidic flow path (curved regulating flow path) on the lower surface of the encapsulation layer is poured into the mold by pouring polydimethylsiloxane (a commercial product, brand Dow Corning, PDMS and curing agent are used in a ratio of 10:1) through the mold, and then heated (80°, 1h) to cure;
[0049] (2) bonding the electrolyte tank to the electrode layer and the glass substrate, wherein the glass substrate, the electrode layer and the electrolyte tank are treated with plasma (300 W, 30 s) respectively, and heated (80° C., 30 min) after bonding, leaving a 1 cm×0.5 cm hole in the middle of the electrolyte tank;
[0050] (3) dripping the salt bridge into the middle hole of the electrolyte tank, and then covering it with a layer of oxygen permeable membrane (e.g., PTFE membrane) of the same size as the hole, and heating it at 37°C to polymerize and solidify the salt bridge, so that the filter layer adheres to the upper surface of the salt bridge, and the middle of the electrolyte tank is sealed and flat;
[0051] (4) bonding the encapsulation layer to the electrolyte tank, treating with plasma (100 W, 30 s), and heating after bonding (80 ° C, 30 min). A 1 cm × 0.1 cm curved flow path is provided on the lower surface of the encapsulation layer, and a liquid inlet and a liquid outlet are provided at both ends of the flow path;
[0052] (5) Bonding conductive silver glue and lead wire: The conductive wire is bonded to the end of the lead wire of the electrode layer with conductive silver glue and heated at 60°C for curing; UV curing glue is applied to the connection area between the conductive wire and the lead wire and irradiated with UV lamp for 5 minutes to achieve curing, thereby achieving the purpose of insulation.
[0053] The preparation process of the electrode layer is as follows: inkjet printing gold ink and silver ink on a glass substrate, and heating and sintering, 100 μL of 50 mmol / L FeCl3 chloride electrode is added to the reference electrode for 20 seconds, and after printing, a heating plate (C-MAG HP 10, IKATHERM, Germany) is used to heat and sinter at 250°C for 2 hours. The inkjet printer used is the Jetlab4 inkjet printing system of MicroFab Company in the United States; the gold ink used is UTDAuIJ ink of UT Dots, and the silver ink used is Smart'Ink S-CS01130 ink of Sigma Company.
[0054] The above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology is as follows Figure 2 As shown, Co is the oxygen partial pressure outside the oxygen permeable membrane, and Ci is the oxygen partial pressure inside the oxygen permeable membrane. During measurement, a certain voltage is applied between the two electrodes. After a period of power-on, the dissolved oxygen concentration inside the sensor basically drops to zero. At this time, due to the concentration difference, the dissolved oxygen in the solution outside the sensor will pass through the polymer membrane into the sensor, diffuse to the surface of the working electrode through the electrolyte between the oxygen permeable membrane and the working electrode, and a redox reaction will occur on the electrode. The potential and current signals are detected by instruments such as electrochemical workstations to measure the oxygen partial pressure in the solution.
[0055] To test the detection performance, the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology is applied as follows:
[0056] The blood gas gas control liquid flows in from the inlet hole of the encapsulation layer, fills the microfluidic flow path and flows out from the outlet hole. Three standard levels of blood gas gas control liquid (level 1, 2, 3 of Radiometer Company, Denmark) and a total of five solutions consisting of a mixture of level 1 and level 2, level 2 and level 3 in a 1:1 volume ratio are used as the test solutions (PO2 range is 0-200mmHg). It can be seen that there is a good linear correlation between the response current value of the PO2 sensor and the PO2 value, and the average absolute error of the measured value of PO2 compared with the true value does not exceed 5mmHg. The measurement results are shown in Tables 1 and Figure 6 , Figure 7 .
[0057] Table 1 Test results of PO2 sensor
[0058]
[0059] It can be seen that the above-mentioned continuous arterial blood oxygen detection chip based on microfluidics technology has the following advantages:
[0060] (1) Design integrated electrochemical sensor elements. The Clark-type dissolved oxygen sensor made by the membrane electrode method to detect PO2 in the blood has a simple principle and high precision. The salt bridge is used to replace the traditional liquid electrolyte, and the chip is small in size and consumes less blood. The oxygen permeable membrane is used to achieve selective detection of oxygen. Overall, high-precision and selective detection of arterial blood oxygen is achieved.
[0061] (2) Design integrated microfluidic channel components and optimize the structural dimensions of the microchannels so that blood can flow smoothly through the surface of the oxygen permeable membrane. A curved flow path structure is used to maximize the contact area between blood and the oxygen permeable membrane and improve the sensitivity of the chip. The overall continuous and real-time detection of arterial blood oxygen is achieved.
[0062] (3) The various structures inside the chip are bonded layer by layer to achieve chip packaging, thereby protecting the sensor elements inside the chip and increasing the service life of the chip.
[0063] In summary, the above-mentioned continuous arterial blood oxygen detection chip as a whole realizes high-precision, selective, continuous and real-time detection of arterial blood oxygen.
[0064] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A continuous arterial blood oxygen detection chip based on microfluidics technology, characterized in that: The invention comprises an integrated electrochemical sensor element and an integrated microfluidic channel element, adopts the Clark-type limiting current sensor principle of a dual-electrode system, uses a salt bridge as a conductive medium, and an oxygen-permeable membrane as a gas filter. A microfluidic pipeline design is adopted, and the flow resistance and blood flow rate are controlled by the microfluidic pipeline, so that blood continuously flows through the surface of the oxygen sensor, thereby realizing continuous detection of arterial blood oxygen. The integrated electrochemical sensor element is composed of a glass substrate (1), an electrode layer (2), a salt bridge (3) and a filter layer (4) in sequence. The glass substrate (1) serves as a substrate, and the electrode layer (2) is provided on its upper surface. On the electrode reaction area of the electrode layer (2) is a salt bridge (3) electrically contacting the electrode, and a filter layer formed on the salt bridge (3). The salt bridge is a hydrogel containing zinc sulfate, and is prepared by the following method: anhydrous zinc sulfate of sulfobetaine methacrylate is added with monobromoacetic acid, and ice-water bath is placed for 30 minutes. in, then adding ammonium sulfate and tetramethylethylenediamine, and finally polymerizing at 37°C to form a salt bridge, the salt bridge is used to fill the electrolyte tank and cover the double electrodes, and the filter layer (4) is suitable for blocking other components in the gas medium except oxygen; the integrated microfluidic channel element is composed of an electrolyte tank (5) and an encapsulation layer (6) in sequence, and the encapsulation layer (6) is arranged above the electrolyte tank (5); the electrolyte tank (5) is partially located above the electrode layer of the integrated electrochemical sensor element, the electrolyte tank (5) is a cavity with an annular structure, with a hole groove in the middle, the hole groove is located directly above the reaction area of the electrode layer, and part of the cavity is located directly above the lead of the electrode layer, the hole groove is filled with a salt bridge, and the salt bridge is liquid before heating and polymerization. After the liquid salt bridge fills the internal cavity of the electrolyte tank, the salt bridge and the oxygen permeable membrane are heated and polymerized, and the upper surface of the electrolyte tank forms a completely sealed cavity structure, which is in electrical contact with the electrode layer in the electrode reaction area.
2. The continuous arterial blood oxygen detection chip based on microfluidics technology according to claim 1, characterized in that: The electrodes are double electrodes, namely a working electrode and a reference electrode, each electrode comprising a lead (2-1) and a reaction area (2-2), and the lead (2-1) and the reaction area (2-2) are in contact and connection.
3. The continuous arterial blood oxygen detection chip based on microfluidics technology according to claim 1, characterized in that: The filter layer (4) is an oxygen permeable membrane, the size of which is the same as that of the salt bridge, and completely covers and adheres to the upper surface of the salt bridge.
4. The continuous arterial blood oxygen detection chip based on microfluidics technology according to claim 1, characterized in that: The lower surface of the encapsulation layer (6) is provided with a microfluid flow path (7) which is in direct contact with the upper surface of the filtration layer (4), and a liquid inlet hole and a liquid outlet hole are respectively provided at both ends of the microfluid flow path.
5. The preparation process of the continuous arterial blood oxygen detection chip based on microfluidics technology according to any one of claims 1 to 4, characterized in that: The specific processing technology is as follows: (1) The electrode layer is attached to the glass substrate by inkjet printing; the microfluidic flow path on the lower surface of the encapsulation layer is poured into the mold through the mold, and then heated and cured to obtain; (2) bonding the electrolyte tank to the electrode layer and the glass substrate, wherein the glass substrate, the electrode layer and the electrolyte tank are treated with plasma respectively, and then heated after bonding; (3) Drop the salt bridge into the middle hole of the electrolyte tank, and then cover it with a filter layer of the same size as the hole, and heat it at 37°C to solidify the salt bridge, so that the filter layer adheres to the upper surface of the salt bridge and achieves sealing and flatness in the middle of the electrolyte tank; (4) bonding the encapsulation layer to the electrolyte tank, treating with plasma, and heating after bonding; (5) Preparation of the conductive part and the insulating part: The conductive wire is glued to the end of the lead of the electrode layer with conductive silver glue and heated at 60°C for curing; UV curing glue is dripped on the connection area between the conductive wire and the lead and irradiated with UV lamp for 5 minutes to achieve curing, thereby achieving the purpose of insulation.
6. The preparation process of the continuous arterial blood oxygen detection chip based on microfluidics technology according to claim 5 is characterized in that: The processing materials selected for the electrolyte tank and the packaging layer are both polydimethylsiloxane, and after surface modification by oxygen plasma, the hydrophilicity of the polydimethylsiloxane surface is improved to improve its anti-adsorption performance and thus improve the anti-coagulation function of the chip.
Citation Information
Patent Citations
Card type potassium ion sensor and method for preparing card type potassium ion sensor
CN103424451A
Continuous arterial blood detection system
CN113588739A
